Company Filing History:
3 out of 162 
1 out of 1,241 
1 out of 821 
Years Active: 2006-2022
Title: The Innovative Contributions of Nigel Hamilton Lovell
Introduction
Nigel Hamilton Lovell is a prominent inventor based in Coogee, Australia. He has made significant contributions to the field of respiratory treatment and electroporation technology. With a total of 7 patents to his name, Lovell's work has had a profound impact on medical technology and patient care.
Latest Patents
One of Lovell's latest patents is focused on the detection of asynchrony in respiratory treatment apparatus. This invention involves a controller or processor that detects respiratory-related conditions, such as asynchrony, by evaluating sensor signals associated with the treatment. The system can identify different events based on a feature set and thresholds, allowing for automated adjustments to the treatment parameters. Another notable patent is an electroporation system designed for controlled localized therapeutics delivery. This system includes an electroporation probe with contiguous electrodes that can be inserted into biological tissue. The probe is connected to a pulse generator that drives the probe using electric pulses, inducing a non-uniform electric field in the tissue. This method aims to achieve predictable electroporation outcomes while minimizing potential toxic effects.
Career Highlights
Throughout his career, Lovell has worked with various organizations, including Newsouth Innovations Pty Limited. His innovative approaches have led to advancements in medical technology, particularly in respiratory care and therapeutic delivery systems.
Collaborations
Lovell has collaborated with notable individuals in his field, including Gregg Jorgen Suaning and Qestra Camille Mulqueeny. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Nigel Hamilton Lovell's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to shape the future of respiratory treatment and localized therapeutics delivery.